2021
DOI: 10.2176/nmccrj.cr.2021-0033
|View full text |Cite
|
Sign up to set email alerts
|

Spinal Cord Diffuse Midline Glioma, H3K27M- mutant Effectively Treated with Bevacizumab: A Report of Two Cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 28 publications
0
4
0
Order By: Relevance
“…We summarized the reported cases, as shown in Table 1 . [ 8 , 19 ] Although our patient could not receive chemoradiotherapy due to his severely disabled condition, the other two patients could. Due to the limited number of documented cases involving DMG arising in the thalamus or the spinal cord, the significance of H3K27 mutation in terms of prognosis remains insufficiently understood.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…We summarized the reported cases, as shown in Table 1 . [ 8 , 19 ] Although our patient could not receive chemoradiotherapy due to his severely disabled condition, the other two patients could. Due to the limited number of documented cases involving DMG arising in the thalamus or the spinal cord, the significance of H3K27 mutation in terms of prognosis remains insufficiently understood.…”
Section: Discussionmentioning
confidence: 96%
“…Very few spinal cord DMG cases with rapid neurological deterioration have been reported. [ 8 , 19 ] Herein, we report a rare case of spinal cord DMG with unusual magnetic resonance (MR) imaging findings and rapid neurological deterioration. We emphasized that it is important to suspect DMG early on neuroimaging and discussed the timing of image acquisition.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, specific markers can be useful in an individualized approach, such as anti-EGFR antibody, which has lower toxicity. Other medications, such as monoclonal antibodies, tyrosine kinase inhibitors, and angiogenesis inhibitors have also been described as possible therapies for diffuse midline gliomas [15].…”
Section: Discussionmentioning
confidence: 99%
“… 14 These tumors are commonly located in the pons, with only a few cases reported in the spinal cord. 15 A recent study of 35 cases of spinal cord H3 K27M-mutant diffuse midline gliomas identified affected locations spanning cervical (29%), cervicothoracic (20%), thoracic (43%), and thoracolumbar (9%) regions. 14 Prognosis tends to be poor with rapid neurologic decline.…”
Section: Discussionmentioning
confidence: 99%